Official ESCRS | European Society of Cataract & Refractive Surgeons
Barcelona 2015 Programme Registration Glaucoma Day 2015 Exhibition Virtual Exhibition Satellite Meetings Hotel Booking Star Alliance
ISTANBUL escrs









Take a look inside the London 2014 Congress

video-icon

Then register to join us
in Barcelona!





Toric trifocal IOLto achieve emmetropia and near vision: 2 years results

Search Abstracts by author or title
(results will display both Free Papers & Poster)

Session Details

Session Title: Pseudophakic IOLs: Trifocal

Session Date/Time: Tuesday 08/09/2015 | 16:30-18:00

Paper Time: 17:26

Venue: Room 10

First Author: : B.Kusa ITALY

Co Author(s): :                        

Abstract Details

Purpose:

To evaluate trifocal toric IOL to manage astigmatism and near vision after cataract surgery

Setting:

C.M.A Centro di Microchirurgia Ambulatoriale Monza ,Milan,Italy

Methods:

Eyes with cataract and corneal astigmatism (1.35 ± 0.43 D) had AT LISA tri toric 939MP implantation. IOL calculations were performed using Z-CALC online calculator, taking into account the surgeon SIA. IOL axis alignment during surgery was accurately performed. Outcomes measurements were subjective refraction, corneal astigmatism using ATLAS™ 9000 Corneal Topography System or Tomey TMS 2 Corneal Tomographer, visual acuity, contrast sensitivity using OPTEC 6500.

Results:

Study included 40 eyes from 26 patients (mean age 66.60 years ± 14.73 [SD]). Preoperatively, mean BCVA and SE were 0.76 ± 0.20 and -1.18 D ± 3.04 respectively. Patients presented with a mean corneal cylinder and mean refractive cylinder of 1.35 D ± 0.43 and 0.86 D ± 0.83 respectively. 2 year postoperatively, mean monocular UCVA and BCVA were 0.87 ± 0.17 and 0.93 ± 0.14 respectively for far vision. Intermediate monocular UCVA was 0.45± 0.29. Near monocular UCVA was 0.80. The mean residual refractive cylinder was 0.25 ± 0.38. Photopic contrast sensitivity were within the normal range for lower spatial frequencies.

Conclusions:

AT LISA toric 909M is an advanced generation multifocal IOL preferably indicated for bilateral implantation. Clinical outcomes indicate that this is an effective multifocal design to correct corneal astigmatism and to achieve emmetropia and near vision.

Financial Interest:

NONE

Back to previous